Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride

Clinical trial NCT02943213 · COMPLETED

Trial details

NCT number: NCT02943213
Sponsor: Cycle Pharmaceuticals Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anti-Psychotic Management of Manifestations of Psychotic Disorders Treatment of Schizophrenia Control Nausea and Vomiting Relief of Restlessness and Apprehension Before Surgery Acute Intermittent Porphyria Adjunct in the Treatment of Tetanus Control Manifestations of the Manic Type of Mani-depressive Illness Relief of Intractable Hiccups

Start date: 2016-11-01
Primary completion: 2016-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.